Publications
- Identification of Fusion Gene Breakpoints is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring on Genomic Level in Patients With PML-RARA, CBFB-MYH11, and RUNX1-RUNX1T12020 | Second Faculty of Medicine
- Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort2019 | Second Faculty of Medicine
- Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort study2024 | Second Faculty of Medicine
- Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy2023 | Second Faculty of Medicine, First Faculty of Medicine
- Posttreatment positivity of BCR::ABL1 in acute lymphoblastic leukemia: Should we keep track?2023 | Second Faculty of Medicine
- Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas2022 | Second Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Physical Education and Sport, First Faculty of Medicine
- Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease2022 | Second Faculty of Medicine
- Frequency and prognostic impact of ZEB2 H1038 and 1072 mutations in childhood B-other acute lymphoblastic leukemia2021 | Second Faculty of Medicine
- DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch2021 | Second Faculty of Medicine
- Pharmacogenetics of the central nervous system-toxicity and relapse affecting the cns in pediatric acute lymphoblastic leukemia2021 | Second Faculty of Medicine
Loading network view...